Samil PharmaceuticalㆍDaewoong PharmaceuticalㆍYuhan CorporationㆍHanmi Pharmaceutical, ↑more than 1%
Il Dong PharmaceuticalㆍIl Dong Holdings ↓4.57%p and 3.14%p
[Newsmp] Foreign investors showed marked differences by stock in pharmaceutical stocks.
Il Dong Pharmaceutical’s foreign ownership plunged by 4.57%p and Il Dong Holdings by 3.14%p, while Il-Yang Pharmaceutical, Samjin Pharmaceutical, and Bukwang Pharmaceutical also decreased by more than 1%p.
Of the 32 stocks with reduced foreign ownership, including Boryung Pharmaceutical, HanAll Biopharma, Ilsung Pharmaceutical, Korea United Pharm., Yuyu Pharma, PharmGen Science, JW Pharmaceutical, ORIENTBIO, and Chong Kun Dang Holdings, 14 stocks fell more than 0.5%p.
Considering that Il-Yang Pharmaceutical was the only stock with foreign ownership of more than 10 % as of the end of June, 14 stocks, which have been reduced by more than 0.5%p, are a considerable number.
On the other hand, there were 12 stocks with an increase in foreign ownership during the same period, including Samil Pharmaceutical, Daewoong Pharmaceutical, Yuhan Corporation, and Hanmi Pharmaceutical with over 1%p, and Daewon Pharmaceutical and Celltrion above 0.5%p.
Meanwhile, as Dong-A ST’s foreign ownership retreated from 20.01% to 19.92%, Green Cross and Celltrion were the only stocks to exceed 20%.
Green Cross had the highest foreign ownership of 22.58%, and Celltrion had 21.20%.
Followed by them, Dong-A ST exceeded 15% with 19.92%, Yuhan Corporation with 19.30%, Kwang Dong Pharmaceutical with 19.10%, and Daewon Pharmaceutical with 17.96%, while Hanmi Pharmaceutical, Whanin Pharmaceutical, Gene One Life Science, and Samsung Biologics maintained double digits.
